News

Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols Caputo et al. Virology Journal (2020) 17:103 https://doi.org/10.1186/s12985-020-01381-3 Abstract Background: Notwithstanding the efforts of direct-acting antivirals (DAAs) for…

We are pleased to announce that Nimagen appointed ABL as its exclusive distribution partner for Sequencing Products in France, Belgium and Luxembourg. The partnership was formalized on March 17th 2020 and will help all labs involved in sequencing to get access to robust and cost-effective solutions…

Single well rRT-PCR assay, including highly sensitive detection of 2 targets and housekeeping internal control, with full automation   Luxembourg (Luxembourg), Metz (France), — July 06 — Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV…

First rt-PCR detection kit CE marked for nasopharyngeal and saliva samples. Improve COVID-19 management with non-invasive, open and sensitive assay.  Luxembourg (Luxembourg), Metz (France), — June 17 — Advanced Biological Laboratories (ABL) announced today the validation of its CE-IVD UltraGene® Com…

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pi…

Optimizing COVID-19 management through highly sensitive SARS-CoV-2 detection test. Luxembourg (Luxembourg), Metz (France) — May 21— Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene® Combo2Screen SARS-CoV-2 assay, now available for in-vitro diagnostics u…

A unique and flexible solution adapted to all virology and microbiology laboratories   LUXEMBOURG CITY (Luxembourg), METZ (France) — May 18th, 2020 — Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its DeepChek®-HIV assays, now available for in-vitro diagnostics.  Intend…

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 13 — Advanced Biological Laboratories (ABL) announced today that its RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially approved by the French ANSM (Agence nationale de sécurité du médicament) as a…

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 7— Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV-2 assay is now available for in-vitro diagnostics use. This test is intended to be used for the qualitative detection of nuc…

We did in March 2020 an external clinical validation with the French National Reference Centre for Covid-19 (CNR). The validation was in two phases. Clinical samples were tested both with the CNR’s RT-PCR reference method (IP2/IP4) and the UltraGene Combo2Screen SARS-CoV-2 Assay. The two phase…

NEWBURYPORT, MA – May 1, 2020: AdvancedDx Biological Laboratories USA Inc. (ABLDx), a virologic diagnostic solutions company, announced today its official launch in the U.S. to commercialize solutions that will advance public health in the Americas. The company will be focused on fighting the COVID-…

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has been validated by the Quality Control for Molecular Diagnostics (QCMD). The QCMD is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation, providing wide-ranging quality a…

Involved in fight against the new Coronavirus, Covid-19, ABL announces the immediat release of new products :  UltraGene Combo 3 genes CoV-2 Assay : 3 targeted genes : RdRp & N-gene for detection, E-gene for confirmation UltraGene-CoV-2-Combo-2 : 2 targeted genes : RdRp & N-gene  UltraGene E…

ABL is pleased to announce our solutions for Detection – Confirmation – Genotyping of 2019 – nCoV :            

ABL is pleased to announce two major updates on its HIV Genotyping Software applications : the full integration of the ViroScore® and DeepChek® software applications with Nadis the availability of a new web-based and disease-specific chromatogram editor